IS7894A - Skammtaform með ofnæmisvaka - Google Patents
Skammtaform með ofnæmisvakaInfo
- Publication number
- IS7894A IS7894A IS7894A IS7894A IS7894A IS 7894 A IS7894 A IS 7894A IS 7894 A IS7894 A IS 7894A IS 7894 A IS7894 A IS 7894A IS 7894 A IS7894 A IS 7894A
- Authority
- IS
- Iceland
- Prior art keywords
- allergy
- dosage form
- dosage
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
- A61J1/035—Blister-type containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
- A61K39/36—Allergens from pollen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2063—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D75/00—Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes, or webs of flexible sheet material, e.g. in folded wrappers
- B65D75/28—Articles or materials wholly enclosed in composite wrappers, i.e. wrappers formed by associating or interconnecting two or more sheets or blanks
- B65D75/30—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding
- B65D75/32—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents
- B65D75/325—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents one sheet being recessed, and the other being a flat not- rigid sheet, e.g. puncturable or peelable foil
- B65D75/327—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents one sheet being recessed, and the other being a flat not- rigid sheet, e.g. puncturable or peelable foil and forming several compartments
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/24—Immunology or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Zoology (AREA)
- Mechanical Engineering (AREA)
- Cell Biology (AREA)
- Composite Materials (AREA)
- Biotechnology (AREA)
- Ophthalmology & Optometry (AREA)
- Pulmonology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42908602P | 2002-11-26 | 2002-11-26 | |
DKPA200201825 | 2002-11-26 | ||
DKPA200300279 | 2003-02-24 | ||
PCT/DK2003/000814 WO2004047794A2 (en) | 2002-11-26 | 2003-11-26 | An allergen dosage form |
Publications (1)
Publication Number | Publication Date |
---|---|
IS7894A true IS7894A (is) | 2005-06-14 |
Family
ID=32397517
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IS7894A IS7894A (is) | 2002-11-26 | 2005-06-14 | Skammtaform með ofnæmisvaka |
Country Status (17)
Country | Link |
---|---|
US (6) | US20040166123A1 (is) |
EP (2) | EP1567123A2 (is) |
JP (2) | JP5442924B2 (is) |
KR (2) | KR101281147B1 (is) |
CN (1) | CN101816787A (is) |
AU (3) | AU2003280324A1 (is) |
BR (1) | BR0316564A (is) |
CA (1) | CA2507551A1 (is) |
CO (1) | CO5690534A2 (is) |
HK (1) | HK1087008A1 (is) |
IL (1) | IL168733A (is) |
IS (1) | IS7894A (is) |
MX (2) | MXPA05005528A (is) |
NO (1) | NO20053142L (is) |
NZ (1) | NZ540850A (is) |
PL (1) | PL218350B1 (is) |
WO (2) | WO2004047793A1 (is) |
Families Citing this family (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2116257T3 (da) | 2000-08-09 | 2013-02-04 | Alk Abello As | Parenterale vaccineformuleringer og anvendelser deraf |
US7927600B2 (en) * | 2001-03-30 | 2011-04-19 | Emile Loria | Anti-allergic pharmaceutical composition containing at least one allergen and at least one antihistamine compound |
MXPA05005528A (es) | 2002-11-26 | 2006-04-05 | Alk Abello As | Producto farmaceutico de alergeno. |
WO2005077410A1 (en) | 2004-02-06 | 2005-08-25 | Greer Laboratories, Inc. | Methods and compositions for dosing of allergens |
US20060115499A1 (en) * | 2004-09-27 | 2006-06-01 | Alk-Abello A/S | Liquid allergy vaccine formulation for oromucosal administration |
EP2283811A1 (en) * | 2004-10-19 | 2011-02-16 | Krka Tovarna Zdravil, D.D., Novo Mesto | Solid pharmaceutical composition comprising donepezil hydrochloride |
WO2006050729A2 (en) * | 2004-11-10 | 2006-05-18 | Alk-Abellò A/S | Method of preventive treatment of allergy by mucosal administration of an allergy vaccine |
US20060210590A1 (en) * | 2005-02-03 | 2006-09-21 | Alk-Abello A/S | Minor allergen control to increase safety of immunotherapy |
DK1868642T3 (da) | 2005-03-18 | 2013-06-24 | Cytos Biotechnology Ag | Katte-allergenfusionsproteiner og anvendelser deraf |
EP1933867A1 (en) | 2005-10-04 | 2008-06-25 | Alk-Abello A/S | Solid vaccine formulation |
DK1814516T3 (da) * | 2005-11-04 | 2013-03-25 | Alk Abello As | Anvendelse af en flydende allergivaccineformulering til oromucosal indgivelse |
KR20080070851A (ko) * | 2005-11-04 | 2008-07-31 | 알크-아벨로 에이/에스 | 구강점막 투여용 액상 알레르기 백신 제형의 용도 |
WO2007071257A1 (en) | 2005-12-23 | 2007-06-28 | Alk-Abelló A/S | Method for dissolution testing of pharmaceutical products |
EP1872792A1 (en) * | 2006-06-29 | 2008-01-02 | Biotech Tools S.A. | A method for the production of hydrolyzed allergen |
CN101678012A (zh) * | 2007-06-12 | 2010-03-24 | 阿尔克-阿贝洛有限公司 | 包含抗组胺药的过敏原剂型 |
GB0711683D0 (en) * | 2007-06-16 | 2007-07-25 | Enigma Diagnostics Ltd | Compositions |
WO2009034110A1 (en) | 2007-09-11 | 2009-03-19 | Kobenhavns Universitet | Prevention of type 1 diabetes by administration of gliadin |
DE202008006598U1 (de) * | 2008-04-11 | 2008-10-02 | Alk-Abelló A/S | Allergie-Impfstoff-Formulierung zur mucosalen Verabreichung |
WO2010086989A1 (ja) | 2009-01-29 | 2010-08-05 | 日東電工株式会社 | 口腔内フィルム状基剤及び製剤 |
JP5588688B2 (ja) | 2010-01-28 | 2014-09-10 | 日東電工株式会社 | フィルム状製剤 |
WO2011112788A1 (en) * | 2010-03-12 | 2011-09-15 | Antigen Laboratories, Inc. | Methods of treating allergies with substantially phenol-free carriers |
JP5751868B2 (ja) | 2010-03-30 | 2015-07-22 | 日東電工株式会社 | フィルム状製剤及びその製造方法 |
JP5800527B2 (ja) * | 2010-03-30 | 2015-10-28 | 日東電工株式会社 | 安定化医薬組成物、安定化医薬組成物溶液製剤、フィルム状製剤及びフィルム状製剤の製造方法 |
CN107184971A (zh) * | 2010-04-30 | 2017-09-22 | 艾洛维特有限责任公司 | 经由口腔粘膜变应性脱敏的方法、制品和试剂盒 |
US9724271B2 (en) * | 2010-04-30 | 2017-08-08 | Allovate, Llc | Methods and articles for preventing or reducing risk of developing a hyperallergenic immune system |
EP2575832B1 (en) * | 2010-06-03 | 2017-07-26 | ALK-Abelló A/S | Pharmaceutical product comprising mite allergen extract(s) and a method for the manufacture thereof |
CN108434089B (zh) | 2010-10-08 | 2020-06-16 | R·P·舍勒科技有限责任公司 | 使用淀粉的口服疫苗快速溶解剂型 |
JP5555148B2 (ja) * | 2010-12-10 | 2014-07-23 | 日東電工株式会社 | シート状製剤及びシート状製剤の製造方法 |
JP5875246B2 (ja) * | 2010-12-10 | 2016-03-02 | 日東電工株式会社 | シート状製剤及びシート状製剤の製造方法 |
GB201104537D0 (en) * | 2011-03-17 | 2011-05-04 | Cambridge Entpr Ltd | Treatment for peanut allergy |
FI20115375A0 (fi) | 2011-04-18 | 2011-04-18 | Teknologian Tutkimuskeskus Vtt Oy | Uudet hypoallergeenit |
FI20115374A0 (fi) | 2011-04-18 | 2011-04-18 | Teknologian Tutkimuskeskus Vtt Oy | Uudet hypoallergeenit |
JP5952634B2 (ja) * | 2011-05-20 | 2016-07-13 | 日東電工株式会社 | 医薬組成物およびその製造方法 |
CA2777431A1 (en) | 2011-05-20 | 2012-11-20 | Nitto Denko Corporation | Pharmaceutical composition and method for producing the same |
JP5841433B2 (ja) | 2012-01-11 | 2016-01-13 | 日東電工株式会社 | 口腔内フィルム状基剤及び製剤 |
JP5931449B2 (ja) | 2012-01-11 | 2016-06-08 | 日東電工株式会社 | 医薬組成物及びその製造方法 |
IN2014MN01513A (is) * | 2012-02-07 | 2015-09-11 | Jolla Inst Allergy Immunolog | |
WO2013173697A1 (en) * | 2012-05-17 | 2013-11-21 | The Johns Hopkins University | Orally dissolving thin films containing allergens and methods of making and use |
JP2014034530A (ja) * | 2012-08-07 | 2014-02-24 | Nitto Denko Corp | アレルゲン含有シート状製剤及びその製造方法 |
PL3470432T3 (pl) | 2012-08-21 | 2022-02-07 | Sanofi Biotechnology | Sposoby leczenia lub zapobiegania astmie przez podawanie antagonisty IL-4R |
CN103215236A (zh) * | 2013-01-29 | 2013-07-24 | 中国科学院昆明动物研究所 | 尘螨过敏原Derf8和Derf20及其基因和应用 |
US9492535B2 (en) | 2013-03-14 | 2016-11-15 | Aimmune Therapeutics, Inc. | Peanut formulations and uses thereof |
ES2503516B1 (es) * | 2013-04-03 | 2015-09-09 | Inmunotek, S.L. | Complejo inmunogénico para vacunación y método de obtención |
TWI755763B (zh) | 2013-06-04 | 2022-02-21 | 美商再生元醫藥公司 | 藉由投與il-4r抑制劑以治療過敏及增強過敏原-特異之免疫療法的方法 |
AU2014321402B2 (en) | 2013-09-19 | 2019-07-25 | Allovate, Llc | Toothpaste for delivering allergens to oral mucosa |
EP2952200A1 (en) | 2014-06-04 | 2015-12-09 | Alk-Abelló A/S | Allergen for prophylactic treatment of allergy |
US20170252295A1 (en) | 2014-09-17 | 2017-09-07 | Steerlife India Private Limited | Effervescent composition and method of making it |
WO2016077675A1 (en) | 2014-11-14 | 2016-05-19 | Sanofi Biotechnology | Methods for treating chronic sinusitis with nasal polyps by administering an il-4r antagonist |
US11219594B2 (en) | 2015-12-12 | 2022-01-11 | Steerlife India Private Limited | Effervescent compositions of metformin and processes for preparation thereof |
CA3035202A1 (en) | 2016-09-01 | 2018-03-08 | Regeneron Pharmaceuticals, Inc. | Methods for preventing or treating allergy by administering an il-4r antagonist |
US10359292B2 (en) | 2017-04-05 | 2019-07-23 | International Business Machines Corporation | Deep learning allergen mapping |
US10517834B2 (en) * | 2017-05-16 | 2019-12-31 | Owen Murray | Fast dissolving tablet formulations and methods of making thereof |
MA46269B1 (fr) | 2017-08-18 | 2024-05-31 | Regeneron Pharma | Méthodes de traitement d'une dermatite atopique sévère par administration d'un inhibiteur des il-4r |
US11524019B2 (en) | 2017-08-21 | 2022-12-13 | Glycom A/S | Synthetic composition for reducing allergy symptoms |
HUE064655T2 (hu) | 2017-10-30 | 2024-04-28 | Sanofi Biotechnology | IL-4R antagonista asztma kezelésére vagy megelõzésére szolgáló eljárásban |
FI128016B (en) | 2018-01-04 | 2019-07-31 | Desentum Oy | Recombinant hypoallergenic Ecu c1 polypeptides for use in horse allergy immunotherapy |
US11406563B2 (en) | 2018-07-27 | 2022-08-09 | Société des Produits Nestlé S.A. | Oral immunotherapy unit dose dispensing systems and methods |
EP3836801A4 (en) * | 2018-08-16 | 2022-05-18 | Société des Produits Nestlé S.A. | ORAL PEANUT DESENSITIZATION IMMUNOTHERAPY WITH MAINTENANCE DOSE |
CA3109769A1 (en) * | 2018-08-16 | 2020-02-20 | Biohaven Therapeutics Ltd. | Use of riluzole oral disintigrating tablets for treating diseases |
EP3887804B1 (en) * | 2018-11-30 | 2023-05-03 | F. Hoffmann-La Roche AG | Laser induced breakdown spectroscopy for determining contaminants in lyophilised medications |
EP3941589A1 (en) | 2019-03-21 | 2022-01-26 | Regeneron Pharmaceuticals, Inc. | Combination of il-4/il-13 pathway inhibitors and plasma cell ablation for treating allergy |
WO2020231843A1 (en) | 2019-05-10 | 2020-11-19 | Aimmune Therapeutics, Inc. | Methods for improving the quality of life of a patient with a peanut allergy |
CN114173819A (zh) | 2019-08-05 | 2022-03-11 | 瑞泽恩制药公司 | 通过施用il-4r拮抗剂治疗过敏和增强过敏原特异性免疫疗法的方法 |
JP7050734B2 (ja) * | 2019-09-30 | 2022-04-08 | 鳥居薬品株式会社 | 舌下アレルゲン免疫療法におけるフィルム製剤 |
US11672761B2 (en) | 2020-11-16 | 2023-06-13 | Orcosa Inc. | Rapidly infusing platform and compositions for therapeutic treatment in humans |
Family Cites Families (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US57856A (en) * | 1866-09-11 | Improvement in cultivators | ||
US278877A (en) * | 1883-06-05 | Ribbon or label holder for hats | ||
US44351A (en) * | 1864-09-20 | Gang-plow | ||
US107208A (en) * | 1870-09-06 | Improvement in apparatus for the manufacture of illuminating-gas | ||
US271079A (en) * | 1883-01-23 | Grain weigher and tally | ||
US346622A (en) * | 1886-08-03 | Bedstead | ||
US2378383A (en) * | 1942-10-17 | 1945-06-19 | Brush Dev Co | Transient signal recordingreproducing device |
US3816314A (en) * | 1972-05-31 | 1974-06-11 | Exxon Research Engineering Co | Block copolymers of unsaturated ester and a nitrogen containing monomer as v.i.improving and dispersant additives for oils |
DD107208A1 (is) * | 1973-06-04 | 1974-07-20 | ||
GB1548022A (en) * | 1976-10-06 | 1979-07-04 | Wyeth John & Brother Ltd | Pharmaceutial dosage forms |
US4371513A (en) * | 1977-03-25 | 1983-02-01 | W. R. Grace & Co. | Alumina compositions |
US6024983A (en) * | 1986-10-24 | 2000-02-15 | Southern Research Institute | Composition for delivering bioactive agents for immune response and its preparation |
US4822611A (en) | 1986-12-09 | 1989-04-18 | Immunotec, Inc. | Oral hyposensitization in the treatment of allergies |
FR2609895B1 (fr) | 1987-01-28 | 1991-06-28 | Bruttmann Georges | Nouvelles formes galeniques d'allergenes pour administration par voie per- et sub-linguale |
US5244663A (en) * | 1987-01-28 | 1993-09-14 | Medibrevex | Therapeutic method against allergy |
IT1217628B (it) * | 1988-05-18 | 1990-03-30 | Neo Abello Spa | Forma farmaceutica e supporto per la somministrazione di estratti ellergenici |
US5215756A (en) * | 1989-12-22 | 1993-06-01 | Gole Dilip J | Preparation of pharmaceutical and other matrix systems by solid-state dissolution |
JPH0537070A (ja) | 1991-07-26 | 1993-02-12 | Sharp Corp | 分布帰還型半導体レーザ素子の製造方法 |
JPH0597672A (ja) * | 1991-10-08 | 1993-04-20 | Terumo Corp | アミド誘導体含有固形製剤およびその製造方法 |
AU3949093A (en) * | 1992-03-31 | 1993-11-08 | Benzon Pharma A/S | A pharmaceutical formulation |
IL105553A (en) * | 1992-05-06 | 1998-01-04 | Janssen Pharmaceutica Inc | Solid dosage forms consisting of a porous network of matrix that releases a substance that dissipates rapidly in water |
US5343762A (en) | 1992-10-05 | 1994-09-06 | Rosemount Inc. | Vortex flowmeter |
US5343672A (en) * | 1992-12-01 | 1994-09-06 | Scherer Ltd R P | Method for manufacturing freeze dried dosages in a multilaminate blister pack |
US5762961A (en) * | 1996-02-09 | 1998-06-09 | Quadrant Holdings Cambridge Ltd. | Rapidly soluble oral solid dosage forms, methods of making same, and compositions thereof |
US6074673A (en) | 1996-04-22 | 2000-06-13 | Guillen; Manuel | Slow-release, self-absorbing, drug delivery system |
JP2832885B2 (ja) | 1996-09-02 | 1998-12-09 | 株式会社林原生物化学研究所 | スギ花粉アレルゲン |
EP0958834B1 (en) | 1996-11-13 | 2007-07-04 | Meiji Dairies Corporation | Use of peptide-based immunotherapeutic agent |
ES2318869T3 (es) * | 1997-02-20 | 2009-05-01 | Massachusetts Institute Of Technology | Forma de dosificacion que presenta propiedades de dispersion rapida, metodos de uso y procedimiento para su fabricacion. |
DE19713001A1 (de) * | 1997-03-27 | 1998-10-01 | Merck Patent Gmbh | Graminaenpollenallergenmutanten zur spezifischen Immuntherapie, deren Herstellung und Verwendung |
GB9722682D0 (en) | 1997-10-27 | 1997-12-24 | Scherer Ltd R P | Pharmaceutical products |
US20020197321A1 (en) * | 1997-10-27 | 2002-12-26 | Harry Seager | Solid dispersing vaccine composition for oral delivery |
CA2323687C (en) | 1998-03-16 | 2008-11-25 | Alk-Abello A/S | Mutant recombinant allergens |
GB9819484D0 (en) | 1998-09-07 | 1998-10-28 | Univ Bristol | Therapeutic agents |
GB9901819D0 (en) * | 1999-01-27 | 1999-03-17 | Scherer Corp R P | Pharmaceutical compositions |
FR2790387B1 (fr) | 1999-03-01 | 2001-05-18 | Prographarm Laboratoires | Comprime orodispersible presentant une faible friabilite et son procede de preparation |
GB9904629D0 (en) * | 1999-03-02 | 1999-04-21 | Danbiosyst Uk | Oral drug delivery system |
FR2791569B1 (fr) | 1999-03-31 | 2003-05-09 | Pf Medicament | Composition ou structure microporeuse expansee isotrope a dissolution rapide a usage pharmaceutique, veterinaire, dietetique, alimentaire ou cosmetique et son procede d'obtention |
GB9908014D0 (en) * | 1999-04-08 | 1999-06-02 | Scherer Corp R P | Pharmaceutical compositions |
SE9901857D0 (sv) * | 1999-05-21 | 1999-05-21 | Anders Cedergren | Karl Fischer reagent |
WO2001039800A2 (en) | 1999-12-06 | 2001-06-07 | The Board Of Trustees Of The University Of Arkansas | Controlled delivery of antigens |
GB0000891D0 (en) | 2000-01-14 | 2000-03-08 | Allergy Therapeutics Ltd | Formulation |
GB0002386D0 (en) * | 2000-02-02 | 2000-03-22 | Novartis Nutrition Ag | Therapeutic composition |
US6458968B2 (en) * | 2000-06-09 | 2002-10-01 | Rensselaer Polytechnic Institute | Dithiocarboxylic ester synthetic process |
GB0020089D0 (en) * | 2000-08-15 | 2000-10-04 | Smithkline Beecham Biolog | Vaccine Composition |
AU2002223505B2 (en) | 2000-11-16 | 2006-12-07 | Alk-Abello A/S | Mutant allergens |
US6733781B2 (en) * | 2000-12-06 | 2004-05-11 | Wyeth | Fast dissolving tablet |
GB2378383A (en) | 2001-06-06 | 2003-02-12 | Gursharan Moonga | Nasal delivery of pharmaceutical compositions in powder form |
DE10137232A1 (de) * | 2001-07-30 | 2003-02-20 | Pierre Foss | Allergenträger |
WO2003096869A2 (en) | 2002-05-16 | 2003-11-27 | Alk Abelló A/S | Recombinant bet. v. 1. allergen mutants, methods and process thereof |
MXPA05005528A (es) | 2002-11-26 | 2006-04-05 | Alk Abello As | Producto farmaceutico de alergeno. |
US8012505B2 (en) * | 2003-02-28 | 2011-09-06 | Alk-Abello A/S | Dosage form having a saccharide matrix |
DE202008006598U1 (de) * | 2008-04-11 | 2008-10-02 | Alk-Abelló A/S | Allergie-Impfstoff-Formulierung zur mucosalen Verabreichung |
-
2003
- 2003-11-14 MX MXPA05005528A patent/MXPA05005528A/es active IP Right Grant
- 2003-11-14 WO PCT/DK2003/000784 patent/WO2004047793A1/en not_active Application Discontinuation
- 2003-11-14 AU AU2003280324A patent/AU2003280324A1/en not_active Abandoned
- 2003-11-26 WO PCT/DK2003/000814 patent/WO2004047794A2/en active Application Filing
- 2003-11-26 JP JP2005510223A patent/JP5442924B2/ja not_active Expired - Lifetime
- 2003-11-26 PL PL377745A patent/PL218350B1/pl unknown
- 2003-11-26 BR BR0316564-7A patent/BR0316564A/pt not_active Application Discontinuation
- 2003-11-26 EP EP03775108A patent/EP1567123A2/en not_active Withdrawn
- 2003-11-26 KR KR1020127002506A patent/KR101281147B1/ko active IP Right Grant
- 2003-11-26 US US10/723,308 patent/US20040166123A1/en not_active Abandoned
- 2003-11-26 CN CN201010150697A patent/CN101816787A/zh active Pending
- 2003-11-26 KR KR1020057009585A patent/KR20050103187A/ko not_active Application Discontinuation
- 2003-11-26 EP EP11181642.7A patent/EP2436395B1/en not_active Expired - Lifetime
- 2003-11-26 CA CA002507551A patent/CA2507551A1/en not_active Abandoned
- 2003-11-26 AU AU2003283207A patent/AU2003283207C1/en not_active Expired
- 2003-11-26 MX MXPA05005527A patent/MXPA05005527A/es not_active Application Discontinuation
- 2003-11-26 NZ NZ540850A patent/NZ540850A/en not_active IP Right Cessation
-
2005
- 2005-05-23 IL IL168733A patent/IL168733A/en not_active IP Right Cessation
- 2005-06-14 IS IS7894A patent/IS7894A/is unknown
- 2005-06-24 CO CO05062162A patent/CO5690534A2/es not_active Application Discontinuation
- 2005-06-27 NO NO20053142A patent/NO20053142L/no not_active Application Discontinuation
-
2006
- 2006-06-21 HK HK06107051.5A patent/HK1087008A1/xx not_active IP Right Cessation
-
2008
- 2008-04-04 US US12/098,191 patent/US8329196B2/en active Active
- 2008-04-04 US US12/098,150 patent/US9415015B2/en active Active
-
2010
- 2010-03-03 AU AU2010200798A patent/AU2010200798B2/en not_active Expired
-
2011
- 2011-01-06 JP JP2011001387A patent/JP5622594B2/ja not_active Expired - Fee Related
-
2014
- 2014-05-27 US US14/287,920 patent/US9408805B2/en not_active Expired - Lifetime
-
2016
- 2016-07-06 US US15/202,722 patent/US10080719B2/en not_active Expired - Lifetime
-
2017
- 2017-09-08 US US15/699,116 patent/US10471008B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS7894A (is) | Skammtaform með ofnæmisvaka | |
IS7689A (is) | Fjölþátta lyfjaskammtaform | |
DE60330207D1 (de) | le | |
IS7464A (is) | Asíþrómýsín lyfjaskammtaform með minni hliðarverkanir | |
NO20043647L (no) | Bronnsystem | |
DE602004017700D1 (de) | Transmukosen verabreichung | |
DE60310919D1 (de) | Dosiersystem | |
ATE318817T1 (de) | Aza-arylpiperazine | |
DE50301200D1 (de) | Wischblatt | |
NO20033280D0 (no) | Avisningsopplösning | |
DE60326590D1 (de) | Tend lamotrigin | |
NO20040429L (no) | Stromningsrorisolasjonssystem | |
DE60331717D1 (de) | Zündunterbrecherschaltkreis | |
ATA1572002A (de) | Managementspleisskassette | |
DE60336678D1 (de) | Eitaktsp lmotors | |
DE50311317D1 (de) | Dosiereinrichtung | |
DE50309094D1 (de) | Dosiereinrichtung | |
DE50303317D1 (de) | Einschub-leistungsschalter | |
ATA19152002A (de) | Hubkupplung | |
ITMI20021327A1 (it) | Nuove ossialchilpiperazine | |
FR2840006B1 (fr) | Construction demontable | |
AT5889U3 (de) | Brennholzspleisser | |
ATA16872002A (de) | Zwischenstück | |
ATA5582002A (de) | Getränkeerhitzer | |
ATA15092002A (de) | Beckenräumer |